Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarpogrelate for Prevention of Contrast-Induced Nephropathy
NCT01165567Phase 4Unknown
- Sponsor
- SMG-SNU Boramae Medical Center
- Start
- Dec 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sarpogrelate in contrast-induced nephropathy (CIN), sponsored by SMG-SNU Boramae Medical Center. Status: unknown.
02
Drugs
sarpogrelate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT01165567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165567.